Clinical effectiveness of group cognitive-behavioural therapy for depressed older people in primary care. A randomised controlled trial

被引:6
|
作者
Garcia-Pena, Carmen [1 ]
Vazquez-Estupinan, Felipe [2 ]
Avalos-Perez, Fabian [3 ]
Robles Jimenez, Leslie Viridiana [1 ]
Sanchez-Garcia, Sergio [1 ]
Juarez-Cedillo, Teresa [1 ]
机构
[1] IMSS, Unidad Invest Epidemiol & Serv Salud, Area Envejecimiento, CMN SXXI, Mexico City, DF, Mexico
[2] IMSS, CMN SXXI, Hosp Especialidades, Serv Psiquiatria, Mexico City, DF, Mexico
[3] IMSS, Unidad Med Familiar 10, Mexico City, DF, Mexico
关键词
Elderly; depression; cognitive therapy; LATE-LIFE; HEALTH; VALIDATION; SYMPTOMS; VERSION; ADULTS; SF-36; PHQ-9;
D O I
10.17711/SM.0185-3325.2015.004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Depression is associated with an increased use of medical resources and reduced quality of life, cognitive functions, functionality and general health. The treatment of depression is limited by the scarcity of mental health professionals, as reflected in the mental health atlas of the World Health Organization. Method A randomised controlled trial that was not blinded was conducted. Family doctors referred patients older than 60 years who were suspected to have depression to the screening module. The PHQ-9 questionnaire, the Six-Item Screener, and previous diagnosis for psychiatric disorders were collected. Major depression was excluded. Those with a score from two to six on the PHQ-9 and with no comorbidities were referred to the Baseline Phase. A simple random process without blocking was applied. Groups of 7-10 participants engaged in weekly sessions over the course of three months. The control group was referred to their family physician. Reduction in depression score of the PHQ-9 was the main outcome. Results and discussion There were 40 patients in the control group (CG) and 41 in the intervention group (IG). 84% were women, 41% married and 41% reported at least primary education. The mean age for the GC was 69.7 years vs. 71.3 in the GI. The baseline mean MMSE score was 23.7 in the GC and 24.1 in the IG. No significant baseline differences between groups were reported. In the IG, 56% of the participants (n=23) displayed a decrease that was greater than or equal to 5 points on the PHQ-9 compared with 30% (n=12) in the control group. The CT group evidenced a marginal improvement.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [31] Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression Introduction
    Richards, David A.
    Rhodes, Shelley
    Ekers, David
    McMillan, Dean
    Taylor, Rod S.
    Byford, Sarah
    Barrett, Barbara
    Finning, Katie
    Ganguli, Poushali
    Warren, Fiona
    Farrand, Paul
    Gilbody, Simon
    Kuyken, Willem
    O'Mahen, Heather
    Watkins, Ed
    Wright, Kim
    Reed, Nigel
    Fletcher, Emily
    Hollon, Steven D.
    Moore, Lucy
    Backhouse, Amy
    Farrow, Claire
    Garry, Julie
    Kemp, Deborah
    Plummer, Faye
    Warner, Faith
    Woodhouse, Rebecca
    HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (46) : 1 - +
  • [32] Cost-effectiveness of cognitive behaviour therapy versus talking and usual care for depressed older people in primary care
    Holman, Amanda J.
    Serfaty, Marc A.
    Leurent, Baptiste E.
    King, Michael B.
    BMC HEALTH SERVICES RESEARCH, 2011, 11
  • [33] Cognitive-behavioural therapy for depression in people with a somatic disease: meta-analysis of randomised controlled trials
    Beltman, Matthijs W.
    Voshaar, Richard C. Oude
    Speckens, Anne E.
    BRITISH JOURNAL OF PSYCHIATRY, 2010, 197 (01) : 11 - 19
  • [34] TRANSDIAGNOSTIC COGNITIVE-BEHAVIOURAL THERAPY IN PRIMARY CARE: AN IDEAL SETTING
    Gonzalez-Blanch, Cesar
    Ruiz-Torres, Maria
    Cordero-Andres, Patricia
    Umaran-Alfagemel, Olga
    Hernandez-Abellan, Aida
    Munoz-Navarro, Roger
    Cano-Vindel, Antonio
    REVISTA DE PSICOTERAPIA, 2018, 29 (110): : 37 - 52
  • [35] Effectiveness of therapeutic exercise and cognitive-behavioural therapy combined protocol on functionality, pain and joint health in people with haemophilia: Secondary analysis of a controlled trial
    Moreno-Segura, Noemi
    Perez-Alenda, Sofia
    Garcia-Dasi, Maria
    Carrasco, Juan J.
    Marques-Sule, Elena
    Querol, Felipe
    Bonand, Santiago
    Aguilar-Rodriguez, Marta
    HAEMOPHILIA, 2023, 29 (02) : 629 - 639
  • [36] Behavioural Activation versus Treatment as Usual for Depressed Older Adults in Primary Care: A Pragmatic Cluster-Randomised Controlled Trial
    Janssen, Noortje P.
    Lucassen, Peter
    Huibers, Marcus J. H.
    Ekers, David
    Broekman, Theo
    Bosmans, Judith E.
    Van Marwijk, Harm
    Spijker, Jan
    Oude Voshaar, Richard
    Hendriks, Gert-Jan
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2023, 92 (04) : 255 - 266
  • [37] Efficacy of web-based cognitive-behavioural therapy for chronic fatigue syndrome: randomised controlled trial
    Janse, A.
    Worm-Smeitink, M.
    Bleijenberg, G.
    Donders, R.
    Knoop, H.
    BRITISH JOURNAL OF PSYCHIATRY, 2018, 212 (02) : 112 - 118
  • [38] Rumination-focused cognitive-behavioural therapy for residual depression: phase II randomised controlled trial
    Watkins, Edward R.
    Mullan, Eugene
    Wingrove, Janet
    Rimes, Katharine
    Steiner, Herbert
    Bathurst, Neil
    Eastman, Rachel
    Scott, Jan
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (04) : 317 - 322
  • [39] Effectiveness Study of a Cultural Adaptation of Cognitive-Behavioural Therapy-Based Application for Depressive Symptoms in College Students: A Randomised Controlled Trial
    Lin, Yueh-Hsiu
    Wu, Chia-Yi
    Gau, Bih-Shya
    Lin, Cheng-Han
    Ho, Hsiu-Yu
    Lou, Meei-Fang
    JOURNAL OF PSYCHIATRIC AND MENTAL HEALTH NURSING, 2025, 32 (03) : 712 - 722
  • [40] A Self-Guided Online Cognitive Behavioural Therapy to Reduce Fear of Falling in Older People: a Randomised Controlled Trial
    Lim, Mei Ling
    Tran, Mymy
    van Schooten, Kimberley S.
    Radford, Kylie A.
    O'Dea, Bridianne
    Baldwin, Peter
    Delbaere, Kim
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2023, 30 (03) : 455 - 462